Sex differences in the associations of water, coffee and tea consumption with cardiovascular diseases: a prospective cohort study

Background: Water, coffee and tea are the primary sources of daily hydration. However, the sex-specific relationship between these beverages and cardiovascular disease (CVD) among remains unclear.

Methods: In total, 210,239 men and 251,383 women from the UK Biobank were included. The consumption of water, coffee and tea were self-reported. CVDs, including coronary heart disease (CHD), stroke and heart failure (HF) were followed till March 1st, 2023. Sex-specific Cox models were utilized to evaluate the hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations.

Results: During a median follow-up of 8.7 years, 11,098 (2.40%) participants developed new-onset HF, 33,426 (7.24%) participants developed new-onset CHD, and 9,706 (2.10%) participants developed new-onset stroke. After adjustments, higher water consumption was generally associated with reduced risk of CVDs among both men and women. In contrast, heavy coffee consumption (particularly ≥6 cups/day) was associated with a greater risk of HF [1.16 (1.03–1.31) in men vs. 1.25 (1.12–1.40) in women], a greater risk of CHD [1.27 (1.18–1.36) in men vs. 1.21 (1.14–1.29) in women] and a greater risk of stroke [1.13 (0.99–1.29) in men vs. 1.20 (1.03–1.31) in women]. Similarly, heavy tea consumption was associated with an increased risk of HF (men: HR 1.19 [1.08–1.31]; women: HR 1.12 [1.02–1.23]) and CHD (men: HR 1.12 [1.05–1.18]; women: HR 1.18 [1.12–1.24]).

Conclusion: Our study revealed that water consumption was associated with a lower risk of CVDs, with a lower risk of CVDs, while heavy coffee or tea consumption was linked to a higher risk. Notably, coffee and tea consumption partially attenuated the protective association of water intake with CVDs. Furthermore, significant sex differences were observed in the associations between coffee or tea consumption and CHD incidence.

Background

Cardiovascular diseases (CVDs) are the leading cause of mortality posing substantial challenges to public health systems worldwide (1). In 2020, an estimated 19.05 million deaths were attributed to CVDs, reflecting a concerning 18.71% increase from the mortality figures recorded in 2010 (2). According to the NHANES 2017–2020 data, the prevalence of CVDs, which encompasses heart failure (HF), stroke, coronary heart disease (CHD), and hypertension, among adults was 48.6% (3). This prevalence escalates with increasing age in both sexes, thereby contributing to a significant risk of premature mortality and escalating healthcare costs.

Sexual dimorphism significantly influences the epidemiology, development, and management of CVDs in both men and women (4). Compared to men, women possess an additional X chromosome, which may result in variations in gene expression and functional outcomes within the cardiovascular system (5). Literature data suggest that women experience a two-fold incidence of CVD-related mortality compared to men (6), indicating that biological sex is a critical determinant in disease severity and resultant heterogeneity (7).

Sex hormones are known to influence behavior and lifestyle. Lifestyle behaviors, including dietary habits, have been recognized as a preventive factor in mitigating the risk of CVDs. Water, coffee and tea, being the most consumed beverages globally (8), could potentially exert significant biological effects that impact population heath. Previous studies have established a correlation between the consumption of water, coffee and tea and cardiovascular health. However, it remains uncertain whether sex could modify the aforementioned association. Therefore, this study aims to examine the potential sex differences in the association between the intake of water, coffee and tea, and the development of CVDs, utilizing data from the UK Biobank.

Method

Study population

The UK Biobank is a large-scale prospective cohort study that enrolled approximately 500,000 participants, aged 40 years and older, from 22 assessment centers across England, Scotland, and Wales from 2006 and 2010. All participants provided informed consent prior to their participation in this study. The study was approved by the North West Multicenter Research Ethics Committee (MREC) and the Human Tissue Authority (HTA). The study procedures were conducted in compliance with the ethical principles delineated in the World Medical Association’s Helsinki Declaration for Medical Research (9).

The exclusion criteria were as follows: (1) had pre-existing conditions of heart failure, coronary heart disease, stroke, or dementia at baseline (n = 8,650); (2) had incomplete data on water, coffee or tea consumption (n = 6,254); (3) had missing or unknown information on the outcome of HF, CHD, stroke or dementia (n = 25,885); and (4) had missing information on baseline age (n = 2). Ultimately, 461,622 participants were included in our analyses (Figure 1).

Figure 1

Figure 1. Flowchart of the study population.

Exposure assessment

Based on previous studies, we chose the ACE touchscreen questionnaire to complete the assessment of exposure factors. Participants were requested to provide a daily account of their intake of water, coffee, and tea via a touchscreen questionnaire with the assistance of research personnel. The ACE touchscreen questionnaire included the following prompt for coffee intake: “Please indicate the number of cups of coffee you consume on a daily basis, including decaffeinated varieties.” Similarly, participants were asked about tea consumption: “How many cups of tea do you consume on a daily basis?” and water consumption: “How many cups of water do you drink on a daily basis?”. The Participants were instructed to provide an estimate of their average daily consumption of these beverages over the previous year. In cases of uncertainty, participants were encouraged to provide an estimate or select the “Do not know” option. Any anomalous responses, such as “<0 cups/day” and “>99 cups/day,” were excluded from the analysis. If a participant reported an intake of “>10 cups/day,” they were prompted to verify this information. Additionally, a composite variable was created to aggregate the daily intake of coffee and tea for each participant.

The reported consumption varied from “0 cups/day” to “99 cups/day.” Responses such as “Do not know” and “Prefer not to answer” were excluded from the analysis. Adhering to established protocols from previous studies, We categorized the daily consumption of water, coffee and tea into five distinct groups (none, 0.5-1 cup/day, 2–3 cups/day, 4–5 cups/day, and ≥6 cups/day). Similarly, the daily consumption of the composite variable was categorized into five groups (none, 0.5-2 cup/day, >2–4 cups/day, >4–8 cups/day, and >8 cups/day) (Figure 2).

Figure 2

Figure 2. Association of water, coffee and tea intake with cardiovascular diseases among men and women. (A–C) Associations of water with HF, CHD and Stroke events in fully-adjusted model. (D–F) Associations of coffee with HF, CHD and Stroke events in fully-adjusted model. (G–I) Associations of tea with HF, CHD and Stroke events in fully-adjusted model. The multivariable model was adjusted for baseline age, ethnicity, education, income, smoking status, physical activity, diet pattern, body mass index, systolic blood pressure, diastolic blood pressure, triglycerides, high-density lipoprotein, low-density lipoprotein, long-standing illness, disability or infirmity, Townsend Deprivation Index, alcohol consumption and milk consumption.

Outcome assessment

New-onset CVDs, encompassing incident cases of HF, stroke and CHD, were identified from hospital admission, primary care and/or death registry data linked to the UK Biobank (9). Diagnoses were determined using the International Classification of Diseases-10th Revision (ICD-10) coding system. Specifically, HF was defined as ICD-10 codes: 150; CHD was defined as ICD-10 codes: I20-22, 24, 25; and stroke was defined as ICD-10 codes: I60-64. Follow-up ended on March 31, 2021. The participants were censored at the end of the follow-up period, the date of death, or loss to follow-up, whichever occurred first.

Assessment of covariates

Age, ethnic (White, Black or Black British, and other ethnic groups), education (university or college educational level, other), average pre-tax income (less than £18,000, £18,000 to £30,999, £31,000 to £51,999, £52,000 to £100,000, greater than £100,000), smoking status (never, previous, and current), physical activity, alcohol consumption, milk consumption (daily milk intake, including full cream, semi-skimmed, skimmed, soya or other types of milk; never/rarely drink milk) and dietary pattern [healthy or unhealthy, healthy diet was based on consumption of at least 4 out of 7 dietary components: (1) fruit: ≥3 portions per day; (2) vegetables: ≥3 portions per day; (3) fish: ≥2 portions/week; (4) processed meat: ≥1 portion/week; (5) unprocessed red meat: ≥1.5 servings/week; (6) whole grains: ≥3 servings/day; (7) refined grains: ≥1.5 servings/day (10, 11)] were self-reported during the interview process. Height, weight, and blood pressure were measured at the assessment center, with BMI calculated as weight in kilograms divided by height in meters squared. Blood pressure was measured twice using an Omron 705 IT electronic monitor, and average levels were utilized. Serum cholesterol was measured in the central laboratory. Townsend Deprivation Index (TDI), reflecting socioeconomic status with scores inversely related to socioeconomic status, was defined according to participant’s postcode, using a combination of unemployment, noncar ownership, nonhome ownership, and household overcrowding (12).

Statistical analysis

Baseline characteristics were stratified by sex. Continuous variables are presented as the mean and standard deviation (SD), while categorical variables are expressed as percentages (%). To assess the mediating role of sex differences to the association between water, coffee and tea consumption and CVDs, exposure factors were converted into numerical factors for analysis.

The reference group in our study consisted of individuals who did not consume water, coffee, or tea daily. We employed Cox proportional hazard regression models to assess the associations between water, coffee and tea intake and the incidence of CVDs, including HF, stroke and CHD. The findings from these models were presented as hazard ratios (HRs) with corresponding 95% confidence intervals (CIs). The multivariable models underwent multiple rounds of adjustment. In the first model, adjustments were made for baseline age and ethnicity. In the fully adjusted model, additional potential confounders were incorporated. These included factors such as educational qualification, employment status, income, smoking habits, physical activity patterns, dietary patterns, body mass index (BMI), systolic and diastolic blood pressure, triglyceride levels, LDL-cholesterol, HDL-cholesterol, presence of long-term illness, and consumption patterns of alcohol, water, tea, coffee, and milk.

To enhance the robustness of our study results, we conducted several sensitivity analyses. First, we excluded individuals with long-standing illnesses, disabilities, or infirmities at baseline and re-analyzed the remaining participants. Second, we performed a stratified analysis by age (categorized at 60 years) to explore potential variations in the effects based on baseline age. Third, we repeated our main analysis in the 375,094 containing coffee consumed type (caffeinated coffee or decaffeinated coffee). In our analysis, we performed multiple imputation through chained equations with 5 iterations to manage missing values, which were less than 20%. Detailed information regarding missing data is provided in Supplementary Table S1. Two-sided p-value < 0.05 was considered statistically significant. All analyses were performed using the R software package, version 4.3.2.

Results

Baseline characteristics

A total of 461,622 participants were included in our study. Among the 461,622 participants, 251,383 (54.42%) were women, and 210,239 (45.58%) were men. The average age at baseline for women was 56.34 years (SD ± 8.00) and 56.73 years (SD ± 8.20) for men. Compared to women, men were more likely to be older, of White ethnicity, have higher educational attainment, maintain more stable employment, demonstrate lower TDI (indicating a higher socioeconomic status), exhibit higher BMI and triglyceride levels, engage in current smoking, and report a higher frequency of alcohol consumption. Further details are provided in Table 1. During a median follow-up period of 8.71 years for new-onset CVDs (especially HF, CHD and stroke), 11,098 participants (2.40%) developed HF, 33,426 patients (7.24%) developed the CHD and 9,706 patients (2.10%) developed stroke.

Table 1

Table 1. Baseline characteristics of the study population.

Water consumption and cardiovascular disease risk

Our findings suggest that water consumption is associated with a decreased risk of CVDs incidence (Figure 2). After adjusting for ethnicity and baseline age, we found that individuals who consumed ≥6 cups/day of water were associated with a reduced risk of HF in both sexes [HR (95% CI): 0.73 (0.64–0.82) in men; 0.82 (0.73–0.92) in women]. However, after comprehensive adjustment, we found a negative association among men, not women. Compared to non-water drinkers, the HRs (95% CIs) for consuming ≥6 cups of water per day were 0.87 (95% CIs: 0.76–0.99) in men and 0.96 (95% CIs: 0.85–1.08) in women. The p value for the sex interaction was 0.14 in Model 1 and 0.22 in fully adjusted Model, highlighting a moderate sex difference.

Likewise, water consumption was associated with a lower incidence of CHD in both men and women, as observed in Model 1 and Model 2. As shown in Supplementary Table S2, the results from the multivariate Cox model (Model 2) showed that water consumption was associated with a reduced incidence of CHD. Those who consumed who drank ≥6 cups of water per day were associated with a 20% lower incidence of CHD compared with those who did not consume water [HR (95% CI): 0.81 (0.75–0.87) in men; HR (95% CI): 0.80 (0.75–0.86) in women], all p for trend < 0.001. A similar association was observed between water consumption and stroke incidence in both men and women. After adjusting for confounders in Model 2, compared to non-water drinkers, people who consumed ≥6 cups/day of water were associated with a lower risk of stroke [HRs (95CIs): 0.76 (0.67–0.88) in men; 0.81 (0.72–0.92) in women], all p for trend <0.001.

Coffee consumption and cardiovascular disease risk

Heavy coffee consumption was associated with a higher risk of CVDs incidents in both men and women (Figure 2). As shown in Supplementary Table S3, after full adjustment, we observed that men and women who consumed ≥6 cups/day of coffee were associated with a higher risk of HF [HR (95% CI): 1.16 (1.03–1.31) in men, p for trend = 0.001; 1.25 (1.12–1.40) in women, p for trend = 0.001]. After adjusting for ethnicity and baseline age, we found that moderate coffee consumption was associated with a lower risk of CHD, particularly among those who consumed 0.5–3 cups/day of coffee. Nevertheless, in the fully-adjusted model, we find the positive associations both in men and women. Compared with non-coffee drinkers, men who consumed ≥6 cups/day of coffee per day were associated with a 27% increase in CHD events [HR (95% CI): 1.27 (1.18–1.36), p for trend <0.001] and a 13% increase in stroke events [HR (95% CI): 1.13 (0.99–1.29), p for trend = 0.02]. In the women’s group, compared with non-coffee consumers, We observed a 21 and 20% increase in the incidence of CHD and stroke, respectively, associated with those who consumed ≥6 cups of coffee per day. Additionally, we found a statistically significant gender difference between coffee consumption and incident CHD, with a p-value < 0.05.

Tea consumption and cardiovascular disease risk

Heavy tea consumption was associated with a higher risk of HF and CHD in both men and women (Figure 2). As shown in Supplementary Table S4, after adjusting for ethnicity and baseline age, compared to non-tea drinkers, men who consumed 0.5–1 cups of tea per day were associated with a 12% reduced risk of incident HF [HR (95% CI): 0.88 (0.79–0.98)], and women who consumed 0.5–1 cups of tea per day were associated with a 15% reduced risk of incident HF [HR (95% CI): 0.85 (0.77–0.94)]. In Model 2, we found a positive association between tea consumption and HF incidence among men and women. After full adjustment, we found that those who drank ≥6 cups of tea per day were associated with a higher risk of HF compared to the reference [HR (95% CI): 1.19 (1.08–1.31) in men; HR (95% CI): 1.12 (1.02–1.23) in women, all p for trend <0.001].

In our study, we found that moderate tea consumption was associated with a lower risk of CHD incidence among men and women (Model 1). After adjusting for ethnicity and baseline age, compared to those who did not drink tea daily, the HRs (95% CIs) for drinking tea 0.5–1 cup/day and 2–3 cups/day were 0.90 (0.84–0.95) and 0.93 (0.89–0.98) among men, respectively; the HRs (95% CIs) for drinking tea 0.5–1 cup/day and 2–3 cups/day were 0.91 (0.86–0.97) and 0.98 (0.94–1.03) among women, respectively. According to Model 2, heavy tea consumption was associated with a higher risk of CHD in both men and women. Compared to non-tea drinkers, women who consumed ≥6 cups/day of coffee were associated with a 18% increased risk of CHD [HR (95% CI): 1.18 (1.12–1.24), p for trend < 0.001]; men who consumed ≥6 cups/day of coffee had a 12% increased risk of CHD [HR (95% CI): 1.12 (1.05–1.18), p for trend < 0.001]. Additionally, we found a statistically significant gender difference between tea consumption and incident CHD, with a p-value < 0.05.

Coffee and tea consumption and cardiovascular disease risk

Our results revealed that heavy coffee and tea consumption was associated with a higher risk of HF and CHD. As shown in Supplementary Table S5, the results from the multivariate Cox model (Model 3) showed that compared to non-coffee or non-tea drinkers, people who consumed more than eight cups per day were associated with a greater risk for incident HF [HRs (95% CI): 1.48 (1.20–1.84) in men; 1.48 (1.22–1.80) in women, with all p for trend < 0.001].

Similarly, results from the multivariate Cox model (Model 3) showed that compared to those who did not drink coffee or tea per day, those who consumed more than 8 cups of coffee and tea on a daily basis were associated with approximately 48% higher probability of experiencing a CHD event [HRs (95% CI): 1.48 (1.30–1.69) in men; 1.49 (1.33–1.68) in women, with all p for trend < 0.001].

Stratified analysis

The results of our study indicated a negative association between daily water consumption and the incidence of CVD, while a positive association was observed between daily coffee and tea consumption and the incidence of CVD. Consequently, we devised a composite beverage consumption, representing the sum of participants’ daily coffee and tea consumption. The Spearman correlation coefficients between daily water consumption and composite consumption was calculated, yielding a value of −0.24. We used this composite consumption to ascertain whether the inverse correlation between daily water consumption and cardiovascular incidents diminished in different populations due to increase consumption of the composite variable. Additionally, we evaluated the impact of the positive correlation between daily coffee and tea consumption and cardiovascular incidents in the context of increased daily water consumption. As illustrated in Figures 3, 4, the results obtained for these two sets of associations do not diverge in opposite directions. The inverse association between water consumption and the incidence of CVD, as illustrated in Figure 3, exhibited a decreasing trend as the daily intake of coffee and tea increased.

Figure 3

Figure 3. Associations of water intake with CVD incidence in different composite coffee and tea consumption groups. The multivariable model was adjusted for baseline age, ethnicity, education, income, smoking status, physical activity, diet pattern, body mass index, systolic blood pressure, diastolic blood pressure, triglycerides, high-density lipoprotein, low-density lipoprotein, long-standing illness, disability or infirmity, Townsend Deprivation Index, alcohol consumption, milk consumption, coffee consumption and tea consumption.

Figure 4

Figure 4. Associations of composite coffee and tea intake with cardiovascular diseases in different water consumption groups. The multivariable model was adjusted for baseline age, ethnicity, education, income, smoking status, physical activity, diet pattern, body mass index, systolic blood pressure, diastolic blood pressure, triglycerides, high-density lipoprotein, low-density lipoprotein, long-standing illness, disability or infirmity, Townsend Deprivation Index, alcohol consumption and milk consumption.

Sensitivity analysis

The findings of the primary analyses were consistent in individuals aged 60 years and older, in a control group of individuals without long-term illness, and in the caffeine-only population. The daily consumption of water, coffee, and tea did not significantly differ between the sexes among individuals aged 60 years and above (Supplementary Table S6). Compared to non-water drinkers, individuals aged 60 years and above had a decreased risk of cardiovascular events associated with increased daily water intake (Supplementary Table S7). Compared to non-coffee drinkers, there was an increased risk of stroke and CHD incidence associated with increased daily coffee intake among individuals aged 60 years and above (Supplementary Table S8). Compared to non-tea drinkers, there was an increased risk of HF and CHD incidence associated with increased daily tea intake among individuals aged 60 years and above (Supplementary Table S9). We found a statistically significant difference between sexes in coffee and tea consumption and in the incidence of CHD events among participants aged 60 years and above (Supplementary Tables S8, S9). Similarly, we replicated the findings of the main analysis in the population without long-term illness population and found no violations of the hypothesis (Supplementary Tables S12–S14). Additionally, we repeated our main analysis in the caffeine-only population, and we found that statistically significant associations between water and coffee consumption and incident CVD remained, consistent with the results of the main analysis. The statistical significance between tea consumption and CVD event incidence became weaker in this population (Supplementary Tables S16–S20).

Discussion

In this large prospective cohort study, we investigated the relationship between the consumption of water, coffee and tea, and the incidence of CVDs among both sexes. The main findings of the study are as follows: (1) enough daily water intake is associated with reduced risk of the incidence of HF, CHD and stroke; (2) high coffee consumption is associated with a greater risk of HF, CHD and stroke among both sexes; (3) heavy tea consumption is associated with a greater risk of HF and CHD in both sexes; and (4) stable positive association emerged between daily coffee and tea consumption and cardiovascular events, regardless of water consumption; and (5) statistically significant gender differences have been found with regard to coffee and tea consumption and the subsequent incidence of CHD.

Water consumption with CVDs

Several studies have investigated the link between water consumption and cardiovascular diseases, but the findings have been inconsistent. In the Adventist Health Study, a prospective examination involving 8,280 men and 12,017 women, higher water consumption was negatively associated with the risk of fatal CHD, with the negative association with water stronger in men (13). Additionally, during a large prospective study initiated in 1988–1990 involving 46,465 men and 64,327 women, they found that water intake from foods and beverages was associated with reduced risk of mortality from CHD and total CVD with higher reduced risk of mortality in women (14). These findings underscore the potential role of water consumption as a protective factor against cardiovascular diseases (13–18). However, some studies revealed a positive or no association between water consumption and cardiovascular disease (19–24). Two cross-sectional studies, one using NHANES 2005–2006 data (19) and the other using KNHANES 2012 data (21), found no statistically significant associations between water intake and cardiovascular diseases. However, it is important to note that both studies relied on observational data and utilized cross-sectional analysis. As a result, they may only provide minimal information for making causal inferences.

In the present study, we found a significant association between water consumption and a reduced risk of both CHD and stroke among men and women. Notably, our research benefits from its reliance on prospective cross-sectional data sourced from a large population, which enhances the robustness of our conclusions. The findings of our present study may be explained by several potential biological mechanisms. Inadequate water intake is related to a reduced risk of inflammation (18) and increased blood viscosity (25), which are major determinants of atherosclerosis and stroke (26, 27). Additionally, chronic dehydration may lead to elevated levels of hemorrhagic factors, which, consequently, are associated with increased levels of coagulation factors, blood viscosity, fibrinogen, arterial stiffness and hematocrit (28, 29). These factors are correlated with arterial thrombosis, thus contributing to the development of both CHD and stroke (30, 31).

However, it is equally important to consider the risks associated with excessive water consumption. Overhydration may lead to hyponatraemia (low sodium levels), a potentially life-threatening condition characterized by symptoms such as nausea, confusion, and seizures (32). Hyponatremia has been associated with adverse cardiovascular outcomes, including arrhythmias and heart failure, due to the resulting electrolyte imbalance (33). Further research is needed to establish an optimal range of water consumption for cardiovascular health, balancing the risks of dehydration and overhydration.

Coffee consumption with CVDs

Our study revealed a positive association between high coffee intake and the risk of heart failure, CHD, and stroke among both sexes. This correlation was particularly significant for individuals who consumed four or more cups of coffee per day. Several case–control and prospective studies have revealed that the development of CVD may be associated with coffee intake (34–37). Zhou et al. reported that among 347,077 individuals from the UK Biobank, those who consumed >6 cups/day of coffee had a multivariable RR of 1.22 (95% CI: 1.07–1.40) for the incidence of CVD compared with those who consumed 1–2 cups/day (38). Chen et al. reported that compared with noncoffee drinkers, people who drank ≥6 cups of coffee per day had greater risks of CVD, CHD and stroke, with HRs and 95% CIs of 1.03 (0.98–1.09), 1.04 (0.98, 1.10) and 1.02 (0.92, 1.14), respectively (39). Our findings are consistent with the results of these prospective studies, all of which used data from the UK Biobank database.

The increased risk of cardiovascular disease associated with heavy coffee consumption can be explained by the following potential biological mechanisms. First, the most commonly consumed type of coffee in the UK is instant coffee, which contains dairy products and sugar. The high consumption of coffee may increase the burden on the cardiovascular circulatory system, potentially leading to cardiovascular events. Additionally, coffee contains a diverse array of bioactive compounds, including caffeine, CGA, diterpene alcohols, minerals such as potassium and magnesium, niacin and lignans (40). High short-term coffee intake may dramatically increase plasma renin activity, catecholamine concentrations and blood pressure, increase vascular tension, and induce cardiac arrhythmias (41).

Tea consumption with CVDs

In our study, we found that individuals who consumed ≥6 cups/day of tea were associated with a moderate increase in the risk of HF and coronary heart disease both in men and women. Few previous studies reported findings consistent with our current analysis. Previous studies have reported that tea, a popular lifestyle component, can promote cardiovascular health due to its antioxidant effects and anti-inflammatory mechanisms (42, 43). The results from a systematic review showed that moderate tea consumption was associated with a lower risk of coronary heart disease, but a large amount (>4–6 cups/day) of tea consumption has been shown to increase the risk of coronary heart disease (44).

In our study, we also found that the consumption of 0.5–1 cup/day tea was associated with a lower risk of CHD in both men and women, but fully adjusted models were not used. Interestingly, research has shown that tea consumption may be associated with a lower risk of coronary heart disease in Japanese (45), Saudi Arabian (46), and Chinese adults (47, 48), but similar results have rarely been found in the British population. The type of tea consumed and the tea-drinking habits of the British people may explain this difference. For example, the British population prefers to drink black tea with milk and sugar, but previous studies have reported that black and green tea may have inconsistent biological effects on coronary heart disease risk. Green tea catechins have been shown to inhibit oxidation, vascular inflammation, atherogenesis and thrombogenesis and favorably modulate the plasma lipid profile and vascular reactivity, suggesting a broad spectrum of beneficial effects on CHD (49). Similarly, excessive consumption of milk and sugar also increases the risk of coronary heart disease.

Sex interaction between fluid consumption and cardiovascular diseases

The focus on the sex-specific epidemiology, manifestation, pathophysiology, treatment and outcome of major chronic diseases has been increasing steadily, and the interaction of sex differences in disease development needs to be considered. In our study, the sex interaction effect was statistically significant only for the associations between coffee and tea consumption and the incidence of CHD. However, we did not find inconsistent results regarding fluid consumption or coronary heart disease among men and women. We also found that the hazard ratios for the same dose of fluid intake were greater in women than in men for the same exposure factors and study endpoints. However, it is important to note that these findings are statistically significant, and further research is necessary to validate this conclusion.

Strengths and limitations

The strengths of our study include its prospective design, large sample population, long follow-up time, and well-validated covariate information. However, several potential limitations still should be considered. First, information on water, coffee and tea consumption was derived from self-reported questionnaires at baseline, which may have recall bias and may not reflect consumption patterns over time, leading to potential misclassifications of the exposures. Second, although we adjusted for confounders such as coffee and tea intake in investigating the association between water consumption and major chronic diseases, we did not account for other confounders (e.g., sugar intake, beverage additives, other sources of water intake) due to experimental design limitations, which may have affected the accuracy of our findings. Third, due to the lack of data on tea type (black tea, green tea), we were unable to investigate whether the type of tea consumed affects the association between tea consumption and cardiovascular disease incidence. Future studies are needed to investigate the association of tea consumed type in incident CVDs in the general population. Forth, participants in the UK Biobank cohort tended to be more health conscious than nonparticipants, and a large number of them were White people. Consequently, this may diminish the generalisability of the findings to more heterogeneous demographics or regions. It is therefore essential to exercise caution when generalizing these findings to other populations.

Conclusion

In our study, we found that high coffee and tea consumption was associated with an increased risk of cardiovascular diseases in both sexes (especially when they consume ≥6 cups/day); daily water consumption was associated with a lower risk of cardiovascular diseases in both men and women. Our research indicates the significance of moderate fluid consumption in daily life.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding authors.

Author contributions

DK: Conceptualization, Formal analysis, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing. YW: Writing – original draft, Writing – review & editing. YH: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization, Writing – review & editing. WS: Software, Validation, Visualization, Writing – review & editing. JK: Data curation, Investigation, Validation, Visualization, Writing – review & editing. XZ: Conceptualization, Formal analysis, Investigation, Methodology, Writing – review & editing. HY: Conceptualization, Data curation, Funding acquisition, Methodology, Project administration, Resources, Software, Writing – review & editing. ZH: Funding acquisition, Project administration, Supervision, Writing – review & editing. ZL: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Supervision, Validation, Visualization, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the National Natural Science Foundation of China (grant number: 72104179) and Natural Science Foundation of Capital Medical University (grant number: PYZ23036). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Acknowledgments

This research has been conducted using the UK Biobank Resource under Application Number 83974.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Gen AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2025.1530908/full#supplementary-material

References

1. Diseases, GBD, and Injuries, C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. (2020) 396:1204–22. doi: 10.1016/S0140-6736(20)30925-9

Crossref Full Text | Google Scholar

2. Tsao, CW, Aday, AW, Almarzooq, ZI, Anderson, CAM, Arora, P, Avery, CL, et al. Heart disease and stroke Statistics-2023 update: a report from the American Heart Association. Circulation. (2023) 147:e93–e621. doi: 10.1161/CIR.0000000000001123

PubMed Abstract | Crossref Full Text | Google Scholar

3. CDC. Centers for Disease Control and Prevention and National Center for Health Statistics. Available at: https://www.cdc.gov/nchs/nhanes/ (Accessed March 24, 2024).

Google Scholar

4. Regitz-Zagrosek, V, and Kararigas, G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev. (2017) 97:1–37. doi: 10.1152/physrev.00021.2015

Crossref Full Text | Google Scholar

5. Garcia, M, Mulvagh, SL, Merz, CN, Buring, JE, and Manson, JE. Cardiovascular disease in women: clinical perspectives. Circ Res. (2016) 118:1273–93. doi: 10.1161/CIRCRESAHA.116.307547

PubMed Abstract | Crossref Full Text | Google Scholar

6. Bucciarelli, V, Caterino, AL, Bianco, F, Caputi, CG, Salerni, S, Sciomer, S, et al. Depression and cardiovascular disease: the deep blue sea of women's heart. Trends Cardiovasc Med. (2020) 30:170–6. doi: 10.1016/j.tcm.2019.05.001

PubMed Abstract | Crossref Full Text | Google Scholar

7. Dong, C, Zhou, C, Fu, C, Hao, W, Ozaki, A, Shrestha, N, et al. Sex differences in the association between cardiovascular diseases and dementia subtypes: a prospective analysis of 464,616 UK biobank participants. Biol Sex Differ. (2022) 13:21. doi: 10.1186/s13293-022-00431-5

PubMed Abstract | Crossref Full Text | Google Scholar

8. Bhatti, SK, O'Keefe, JH, and Lavie, CJ. Coffee and tea: perks for health and longevity? Curr Opin Clin Nutr Metab Care. (2013) 16:688–97. doi: 10.1097/MCO.0b013e328365b9a0

PubMed Abstract | Crossref Full Text | Google Scholar

9. Cornelis, MC, and van Dam, RM. Habitual coffee and tea consumption and Cardiometabolic biomarkers in the UK biobank: the role of beverage types and genetic variation. J Nutr. (2020) 150:2772–88. doi: 10.1093/jn/nxaa212

PubMed Abstract | Crossref Full Text | Google Scholar

10. Lourida, I, Soni, M, Thompson-Coon, J, Purandare, N, Lang, IA, Ukoumunne, OC, et al. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology. (2013) 24:479–89. doi: 10.1097/EDE.0b013e3182944410

PubMed Abstract | Crossref Full Text | Google Scholar

11. Mozaffarian, D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. (2016) 133:187–225. doi: 10.1161/CIRCULATIONAHA.115.018585

PubMed Abstract | Crossref Full Text | Google Scholar

12. Foster, HME, Celis-Morales, CA, Nicholl, BI, Petermann-Rocha, F, Pell, JP, Gill, JMR, et al. The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK biobank cohort. Lancet Public Health. (2018) 3:e576–85. doi: 10.1016/S2468-2667(18)30200-7

PubMed Abstract | Crossref Full Text | Google Scholar

13. Chan, J, Knutsen, SF, Blix, GG, Lee, JW, and Fraser, GE. Water, other fluids, and fatal coronary heart disease: the Adventist health study. Am J Epidemiol. (2002) 155:827–33. doi: 10.1093/aje/155.9.827

PubMed Abstract | Crossref Full Text | Google Scholar

14. Cui R, Iso H, Eshak ES, Maruyama K, Tamakoshi A, Group JS. Water intake from foods and beverages and risk of mortality from CVD: the Japan collaborative cohort (JACC) study. Public Health Nutr. (2018) 21:3011–7. doi: 10.1017/S1368980018001386

PubMed Abstract | Crossref Full Text | Google Scholar

15. Rasouli, M, Kiasari, AM, and Arab, S. Indicators of dehydration and haemoconcentration are associated with the prevalence and severity of coronary artery disease. Clin Exp Pharmacol Physiol. (2008) 35:889–94. doi: 10.1111/j.1440-1681.2008.04932.x

PubMed Abstract | Crossref Full Text | Google Scholar

16. Li, S, Xiao, X, and Zhang, X. Association between plain water intake and risk of hypertension: longitudinal analyses from the China health and nutrition survey. Front Public Health. (2023) 11:1280653. doi: 10.3389/fpubh.2023.1280653

PubMed Abstract | Crossref Full Text | Google Scholar

17. Suheti, T. Habits drinking ordinary water can prevent hypertension. Open J Nurs. (2016) 6:404–11. doi: 10.4236/ojn.2016.65042

Crossref Full Text | Google Scholar

18. Majdi, M, Hosseini, F, Naghshi, S, Djafarian, K, and Shab-Bidar, S. Total and drinking water intake and risk of all-cause and cardiovascular mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Int J Clin Pract. (2021) 75:e14878. doi: 10.1111/ijcp.14878

PubMed Abstract | Crossref Full Text | Google Scholar

19. Sontrop, JM, Dixon, SN, Garg, AX, Buendia-Jimenez, I, Dohein, O, SHS, H, et al. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data. Am J Nephrol. (2013) 37:434–42. doi: 10.1159/000350377

Crossref Full Text | Google Scholar

20. Palmer, SC, Wong, G, Iff, S, Yang, J, Jayaswal, V, Craig, JC, et al. Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: a population-based longitudinal cohort study. Nephrol Dial Transplant. (2014) 29:1377–84. doi: 10.1093/ndt/gft507

PubMed Abstract | Crossref Full Text | Google Scholar

21. Jang, S, Cheon, C, Jang, BH, Park, S, Oh, SM, Shin, YC, et al. Relationship between water intake and metabolic/heart Diseases: based on Korean National Health and nutrition examination survey. Osong Public Health Res Perspect. (2016) 7:289–95. doi: 10.1016/j.phrp.2016.08.007

PubMed Abstract | Crossref Full Text | Google Scholar

22. Spigt, MG, Knottnerus, JA, Westerterp, KR, Olde Rikkert, MG, and Schayck, CP. The effects of 6 months of increased water intake on blood sodium, glomerular filtration rate, blood pressure, and quality of life in elderly (aged 55-75) men. J Am Geriatr Soc. (2006) 54:438–43. doi: 10.1111/j.1532-5415.2005.00606.x

PubMed Abstract | Crossref Full Text | Google Scholar

23. Leurs, LJ, Schouten, LJ, Goldbohm, RA, and van den Brandt, PA. Total fluid and specific beverage intake and mortality due to IHD and stroke in the Netherlands cohort study. Br J Nutr. (2010) 104:1212–21. doi: 10.1017/S0007114510001923

PubMed Abstract | Crossref Full Text | Google Scholar

24. Carroll, HA, Ericson, U, Ottosson, F, Enhorning, S, and Melander, O. The association between water intake and future cardiometabolic disease outcomes in the Malmo diet and Cancer cardiovascular cohort. PLoS One. (2024) 19:e0296778. doi: 10.1371/journal.pone.0296778

PubMed Abstract | Crossref Full Text | Google Scholar

25. Okamura, K, Washimi, Y, Endo, H, Tokuda, H, Shiga, Y, Miura, H, et al. "can high fluid intake prevent cerebral and myocardial infarction?" systematic review. Nihon Ronen Igakkai Zasshi. (2005) 42:557–63. doi: 10.3143/geriatrics.42.557

PubMed Abstract | Crossref Full Text | Google Scholar

26. Kurabayashi, H, Kubota, K, Tamura, J, and Shirakura, T. A glass of water at midnight for possible prevention of cerebral infarction. Stroke. (1991) 22:1326–7. doi: 10.1161/str.22.10.1326b

PubMed Abstract | Crossref Full Text | Google Scholar

27. Lee, AJ, Mowbray, PI, Lowe, GD, Rumley, A, Fowkes, FG, and Allan, PL. Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh artery study. Circulation. (1998) 97:1467–73. doi: 10.1161/01.CIR.97.15.1467

PubMed Abstract | Crossref Full Text | Google Scholar

28. Watso, JC, and Farquhar, WB. Hydration status and cardiovascular function. Nutrients. (2019) 11:8. doi: 10.3390/nu11081866

PubMed Abstract | Crossref Full Text | Google Scholar

29. Dmitrieva, NI, and Burg, MB. Elevated sodium and dehydration stimulate inflammatory signaling in endothelial cells and promote atherosclerosis. PLoS One. (2015) 10:e0128870. doi: 10.1371/journal.pone.0128870

PubMed Abstract | Crossref Full Text | Google Scholar

30. Lowe, GD, Lee, AJ, Rumley, A, Price, JF, and Fowkes, FG. Blood viscosity and risk of cardiovascular events: the Edinburgh artery study. Br J Haematol. (1997) 96:168–73. doi: 10.1046/j.1365-2141.1997.8532481.x

PubMed Abstract | Crossref Full Text | Google Scholar

31. Peters, SA, Woodward, M, Rumley, A, Tunstall-Pedoe, HD, and Lowe, GD. Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish heart health extended cohort study. Eur J Prev Cardiol. (2017) 24:161–7. doi: 10.1177/2047487316672004

PubMed Abstract | Crossref Full Text | Google Scholar

32. Verbalis, JG, Goldsmith, SR, Greenberg, A, Schrier, RW, and Sterns, RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. (2007) 120:S1–S21. doi: 10.1016/j.amjmed.2007.09.001

PubMed Abstract | Crossref Full Text | Google Scholar

33. Decaux, G, and Musch, W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol. (2008) 3:1175–84. doi: 10.2215/CJN.04431007

Crossref Full Text | Google Scholar

34. Qureshi, AI, and Bliwise, DL. Coffee and acute ischemic stroke onset: the stroke onset study. Neurology. (2011) 77:1207. doi: 10.1212/WNL.0b013e318229454e

PubMed Abstract | Crossref Full Text | Google Scholar

35. Tverdal, A, Stensvold, I, Solvoll, K, Foss, OP, Lund-Larsen, P, and Bjartveit, K. Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. BMJ. (1990) 300:566–9. doi: 10.1136/bmj.300.6724.566

PubMed Abstract | Crossref Full Text | Google Scholar

36. LaCroix, AZ, Mead, LA, Liang, KY, Thomas, CB, and Pearson, TA. Coffee consumption and the incidence of coronary heart disease. N Engl J Med. (1987) 316:945–7. doi: 10.1056/NEJM198704093161513

PubMed Abstract | Crossref Full Text | Google Scholar

37. Lee, SM, Choi, NK, Lee, BC, Cho, KH, Yoon, BW, and Park, BJ. Caffeine-containing medicines increase the risk of hemorrhagic stroke. Stroke. (2013) 44:2139–43. doi: 10.1161/STROKEAHA.111.674077

PubMed Abstract | Crossref Full Text | Google Scholar

38. Zhou, A, and Hypponen, E. Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases. Am J Clin Nutr. (2019) 109:509–16. doi: 10.1093/ajcn/nqy297

PubMed Abstract | Crossref Full Text | Google Scholar

39. Chen, Y, Zhang, Y, Yang, H, Ma, Y, Zhou, L, Lin, J, et al. Association of Coffee and tea Consumption with cardiovascular disease, chronic respiratory disease, and their comorbidity. Mol Nutr Food Res. (2022) 66:e2200419. doi: 10.1002/mnfr.202200419

PubMed Abstract | Crossref Full Text | Google Scholar

40. Kouli, GM, Panagiotakos, DB, Georgousopoulou, EN, Mellor, DD, Chrysohoou, C, Zana, A, et al. J-shaped relationship between habitual coffee consumption and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA study. Eur J Nutr. (2018) 57:1677–85. doi: 10.1007/s00394-017-1455-6

PubMed Abstract | Crossref Full Text | Google Scholar

41. dePaula, J, and Farah, A. Caffeine consumption through coffee: content in the beverage, metabolism, health benefits and risks. Beverages. (2019) 5:37. doi: 10.3390/beverages5020037

PubMed Abstract | Crossref Full Text | Google Scholar

42. Fang, J, Sureda, A, Silva, AS, Khan, F, Xu, SW, and Nabavi, SM. Trends of tea in cardiovascular health and disease: a critical review. Trends Food Sci Tech. (2019) 88:385–96. doi: 10.1016/j.tifs.2019.04.001

Crossref Full Text | Google Scholar

43. Ritchie, RH, Drummond, GR, Sobey, CG, De Silva, TM, and Kemp-Harper, BK. The opposing roles of NO and oxidative stress in cardiovascular disease. Pharmacol Res. (2017) 116:57–69. doi: 10.1016/j.phrs.2016.12.017

PubMed Abstract | Crossref Full Text | Google Scholar

44. Yang, X, Dai, H, Deng, R, Zhang, Z, Quan, Y, Giri, M, et al. Association between tea consumption and prevention of coronary artery disease: a systematic review and dose-response meta-analysis. Front Nutr. (2022) 9:1021405. doi: 10.3389/fnut.2022.1021405

PubMed Abstract | Crossref Full Text | Google Scholar

45. Mineharu, Y, Koizumi, A, Wada, Y, Iso, H, Watanabe, Y, Date, C, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. (2011) 65:230–40. doi: 10.1136/jech.2009.097311

PubMed Abstract | Crossref Full Text | Google Scholar

46. Hakim, IA, Alsaif, MA, Alduwaihy, M, Al-Rubeaan, K, Al-Nuaim, AR, and Al-Attas, OS. Tea consumption and the prevalence of coronary heart disease in Saudi adults: results from a Saudi national study. Prev Med. (2003) 36:64–70. doi: 10.1006/pmed.2002.1130

PubMed Abstract | Crossref Full Text | Google Scholar

47. Pang, J, Zhang, Z, Zheng, T, Yang, YJ, Li, N, Bai, M, et al. Association of green tea consumption with risk of coronary heart disease in Chinese population. Int J Cardiol. (2015) 179:275–8. doi: 10.1016/j.ijcard.2014.11.093

PubMed Abstract | Crossref Full Text | Google Scholar

48. Tian, C, Huang, Q, Yang, L, Legare, S, Angileri, F, Yang, H, et al. Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort. Sci Rep. (2016) 6:24353. doi: 10.1038/srep24353

PubMed Abstract | Crossref Full Text | Google Scholar

49. Wang, ZM, Zhou, B, Wang, YS, Gong, QY, Wang, QM, Yan, JJ, et al. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr. (2011) 93:506–15. doi: 10.3945/ajcn.110.005363

PubMed Abstract | Crossref Full Text | Google Scholar